Figure 2.
The interactions of pyrazolopyrimidine (8) with different regions of GSK-3 during silico docking analysis. (Reproduced from Peat et al.20 with permission from Elsevier Science.)
The interactions of pyrazolopyrimidine (8) with different regions of GSK-3 during silico docking analysis. (Reproduced from Peat et al.20 with permission from Elsevier Science.)